“`html
ResMed Inc. (RMD) reported a significant earnings boost in the first quarter of fiscal 2026, with adjusted earnings per share (EPS) standing at $2.55, a 15.9% increase year-over-year, surpassing the Zacks Consensus Estimate by 2.41%. The company also saw revenue rise by 9.1% year-over-year to $1.34 billion, exceeding expectations by 0.94%.
In Q1, revenue from the Sleep and Breathing Health segment increased by 9.5% to $1.17 billion, while the Residential Care Software segment saw a growth of 5.9% to $166.1 million. ResMed’s adjusted operating income reached $482.1 million, reflecting a margin expansion of 291 basis points to 36.1%.
At the end of Q1 fiscal 2026, ResMed held $1.38 billion in cash and equivalents, up from $1.21 billion at the close of fiscal 2025. The company executed share repurchases totaling $150 million and paid out $88 million in dividends.
“`
